Items where Author is "Sharifipour, E."
![]() | Up a level |
Article
(2022) Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS
(2022) Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years. Multiple Sclerosis and Related Disorders. p. 103777. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)
(2022) Socioeconomic status of Iranian patients with multiple sclerosis in relation to disease-induced disability. Multiple Sclerosis Journal. p. 935. ISSN 1352-4585
(2022) The association between reproductive characteristics and disability in iranian female patients with multiple sclerosis: a nationwide registry based cross-sectional study. Multiple Sclerosis Journal. pp. 185-186. ISSN 1352-4585
(2021) Low-dose versus standard-dose alteplase for intravenous thrombolysis in patients with acute ischemic stroke in Iran: Results from the safe implementation of treatments in stroke registry. CURRENT JOURNAL OF NEUROLOGY. pp. 208-213. ISSN 2717-011X J9 - CURR J NEUROL
(2020) Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. International Immunopharmacology. ISSN 1567-5769
(2016) Situation of Stroke Thrombolytic Therapy in Iran. International Journal of Stroke. p. 84. ISSN 1747-4930